Viewing Study NCT04803994


Ignite Creation Date: 2025-12-25 @ 2:00 AM
Ignite Modification Date: 2025-12-26 @ 12:23 AM
Study NCT ID: NCT04803994
Status: RECRUITING
Last Update Posted: 2025-01-07
First Post: 2021-03-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage HepatoCellular Carcinoma
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module